AKOYA Bio - Logo - Standard Centered.png
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023 08:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Participate at Two Upcoming Investor Conferences
June 12, 2023 16:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
June 08, 2023 00:55 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its public offering of 8,700,000...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Public Offering of Common Stock
June 07, 2023 16:08 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has launched an underwritten public offering...
AKOYA Bio - Logo - Standard Centered.png
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
May 08, 2023 16:05 ET | Akoya Biosciences, Inc.
Q1 2023 revenue $21.4 million, 27% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
April 27, 2023 08:00 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has shipped it’s 1,000th instrument, a...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
April 12, 2023 08:00 ET | Akoya Biosciences, Inc.
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at AACR 2023 Annual Meeting (Akoya booth #1713) ...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
April 12, 2023 08:00 ET | Akoya Biosciences, Inc.
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion systemFirst protein panel commercially available at AACR 2023 Annual Meeting and first RNA panel...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
April 06, 2023 08:00 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Leadership Transition
March 20, 2023 16:00 ET | Akoya Biosciences, Inc.
Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass., March 20, 2023 (GLOBE NEWSWIRE) --...